NATIONAL CANCER CENTER;CHUGAI SEIYAKU KABUSHIKI KAISHA
发明人:
Shuichi MITSUNAGA,Atsushi OCHIAI,Masafumi IKEDA
申请号：
US15955960
公开号：
US20180236068A1
申请日:
2018.04.18
申请国别(地区):
US
年份:
2018
代理人:
摘要：
We achieved the present invention on the basis of the finding that an excellent therapeutic effect against pancreatic cancer can be obtained by administering an IL-6 inhibitor and an antimetabolite to pancreatic cancer patients. We also found that metastatic lesions from human pancreatic cancer can be reduced and ascites can be eliminated.
